Search research articles
Contact Us
Filters
Showing results (171-180 of 269) with videos related to
Page
of 27
Sort By:
BMC Medical Genomics
|
December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Geno Guerra, George Wendt, Lucie McCoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial
Edith A Perez, Monica M Reinholz, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831
Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
The Lancet. Oncology
|
December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
John R Prensner, Shuang Zhao, Nicholas Erho, et al.
Neuro-Oncology
|
January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Geno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology
|
February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Kristen L Drucker, Arijit Panda, Paul A Decker, et al.
Neuro-Oncology Advances
|
July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variants
Matthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
European Journal of Haematology
|
October 2, 2018
Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia
Umut Aypar, Stephanie A Smoley, Beth A Pitel, et al.
Page
of 27
Search research articles
Search
Showing results (171-180 of 269) with videos related to
Sort By:
Page
of 27
BMC Medical Genomics
|
December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Geno Guerra, George Wendt, Lucie McCoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial
Edith A Perez, Monica M Reinholz, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831
Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
The Lancet. Oncology
|
December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
John R Prensner, Shuang Zhao, Nicholas Erho, et al.
Neuro-Oncology
|
January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Geno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology
|
February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Kristen L Drucker, Arijit Panda, Paul A Decker, et al.
Neuro-Oncology Advances
|
July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variants
Matthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
European Journal of Haematology
|
October 2, 2018
Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia
Umut Aypar, Stephanie A Smoley, Beth A Pitel, et al.
Page
of 27